Generation of an induced pluripotent stem cell line (TRNDi005-A) from a Mucopolysaccharidosis Type IVA (MPS IVA) patient carrying compound heterozygous p.R61W and p.WT405del mutations in the GALNS gene

. Author manuscript; available in PMC: 2021 Apr 14.

Published in final edited form as: Stem Cell Res. 2019 Feb 15;36:101408. doi: 10.1016/j.scr.2019.101408

Resource table.

Unique stem cell line identifier	TRNDi005-A
Alternative name(s) of stem cell line	HT438A
Institution	National Institutes of Health National Center for Advancing Translational Sciences Bethesda, Maryland, USA
Contact information of distributor	Dr. Wei Zheng, wei.zheng@nih.gov
Type of cell line	iPSC
Origin	Human
Additional origin info	Age: 43-year-old Sex: Male Ethnicity: Caucasian
Cell Source	Skin dermal fibroblasts
Clonality	Clonal
Method of reprogramming	Integration-free Sendai viral vectors
Genetic Modification	NO
Type of Modification	N/A
Associated disease	Mucopolysaccharidosis type IVA (MPS IVA)
Gene/locus	GALNS^R61W; GALNS^WT405del
Method of modification	N/A
Name of transgene or resistance	N/A
Inducible/constitutive system	N/A
Date archived/stock date	06-29-2017
Cell line repository/bank	N/A
Ethical approval	NIGMS Informed Consent Form was obtained from patient at time of sample submission. Confidentiality Certificate: CC-GM-15-004